| Apr'20 | Jan'20 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 | Dec'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||||||||||
Net (loss) earnings | |||||||||||||||||
3,900 | 11,600 | 15,800 | 8,000 | 13,300 | 19,900 | 28,300 | 42,900 | 49,700 | 52,200 | 52,000 | 59,200 | 66,200 | 66,000 | 69,000 | 0 | 0 | 0 |
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||||||||||||||
Share-based compensation expense | |||||||||||||||||
12,600 | 12,300 | 11,700 | 11,200 | 10,900 | 10,500 | 10,000 | 9,800 | 9,500 | 8,200 | 8,400 | 8,600 | 8,500 | 9,700 | 9,500 | 0 | 0 | 0 |
Depreciation | |||||||||||||||||
20,800 | 18,900 | 23,500 | 28,700 | 29,600 | 30,900 | 26,000 | 22,300 | 18,900 | 18,700 | 16,900 | 13,200 | 13,900 | 10,400 | 9,800 | 0 | 0 | 0 |
Amortization of intangible assets | |||||||||||||||||
17,300 | 16,500 | 15,700 | 15,100 | 15,100 | 15,700 | 16,200 | 16,800 | 16,300 | 13,400 | 10,500 | 7,500 | 5,200 | 5,300 | 5,500 | 0 | 0 | 0 |
Deferred taxes | |||||||||||||||||
0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
Income from equity method investments | |||||||||||||||||
-3,300 | -2,400 | -2,300 | 0 | 1,000 | 5,400 | 3,900 | 1,500 | 4,100 | 500 | 1,300 | 2,500 | -900 | -700 | -1,600 | 0 | 0 | 0 |
Amortization of deferred loan costs | |||||||||||||||||
2,400 | 2,400 | 2,400 | 2,400 | 2,300 | 2,300 | 2,300 | 2,900 | 3,000 | 2,400 | 1,800 | 0 | 0 | 0 | - | - | - | - |
Other, net | |||||||||||||||||
400 | -700 | -800 | -2,300 | -2,100 | -800 | -700 | -600 | -1,200 | -1,600 | -1,800 | -700 | -1,300 | -300 | -700 | 0 | 0 | 0 |
Changes in assets and liabilities, net of effects of acquisition: | |||||||||||||||||
Accounts receivable | |||||||||||||||||
-100 | -12,700 | -14,800 | -1,600 | -4,000 | 4,000 | -9,000 | -2,200 | -11,000 | -600 | 23,100 | 6,200 | 3,200 | -10,300 | 4,600 | 0 | 0 | 0 |
Inventories | |||||||||||||||||
18,900 | 10,200 | 11,100 | 15,800 | 17,800 | 14,800 | 2,400 | -7,100 | 0 | 7,100 | 4,200 | 25,000 | 27,200 | 26,500 | 23,500 | 0 | 0 | 0 |
Prepaid expenses and other assets | |||||||||||||||||
4,100 | -4,300 | -4,300 | -3,900 | -3,200 | -5,700 | -2,000 | -100 | 1,000 | 7,700 | 10,100 | 8,700 | 8,600 | 3,900 | 900 | 0 | 0 | 0 |
Accounts payable | |||||||||||||||||
14,700 | 6,900 | -9,000 | 3,600 | 9,700 | 3,200 | 5,200 | -8,500 | -9,600 | 8,300 | 4,900 | 10,300 | 9,100 | -4,600 | -1,900 | 0 | 0 | 0 |
Accrued liabilities and other current and long-term operating liabilities | |||||||||||||||||
16,200 | 3,000 | 10,900 | -3,700 | -8,600 | -8,200 | -10,200 | 11,600 | 19,700 | 31,600 | 28,100 | 12,500 | 12,100 | 9,300 | 2,800 | 0 | 0 | 0 |
Deferred revenues | |||||||||||||||||
-2,100 | -4,600 | -5,200 | 400 | 900 | 1,500 | 2,400 | 500 | 0 | -1,600 | -1,600 | -2,000 | 0 | 2,000 | 1,900 | 0 | 0 | 0 |
Net cash provided by operating activities | |||||||||||||||||
62,900 | 74,900 | 71,900 | 67,500 | 72,700 | 65,200 | 85,300 | 82,200 | 87,700 | 96,100 | 75,200 | 79,600 | 80,300 | 87,300 | 74,200 | 0 | 0 | 0 |
Cash flows from investing activities: | |||||||||||||||||
Purchases of property, plant and equipment | |||||||||||||||||
26,400 | 24,500 | 19,800 | 18,400 | 21,100 | 21,200 | 20,400 | 27,900 | 20,400 | 17,800 | 20,200 | 12,300 | 16,500 | 23,400 | 28,900 | 0 | 0 | 0 |
Sale of available-for-sale securities | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,600 | 0 | 0 | 0 |
Acquisitions of businesses, net of cash acquired | |||||||||||||||||
70,700 | 70,700 | 69,500 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Investments in privately-held companies | |||||||||||||||||
0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Other | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | - | 0 |
Net cash used in investing activities | |||||||||||||||||
-102,900 | -100,400 | -93,200 | -96,300 | -25,900 | -26,000 | -25,200 | -23,700 | -292,200 | -290,300 | -292,000 | -288,300 | -17,800 | -24,000 | -21,600 | 0 | 0 | 0 |
Cash flows from financing activities: | |||||||||||||||||
Net transfers from parent | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | - | - | - |
Net transfers from parent | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | -36,700 | 0 | 0 | 0 |
Borrowings under credit agreements | |||||||||||||||||
101,900 | 84,400 | 85,400 | 79,000 | 7,000 | 12,000 | 10,000 | 15,000 | 553,000 | 751,000 | 749,000 | 0 | 0 | 0 | - | - | - | - |
Repayments of borrowing under credit agreements | |||||||||||||||||
71,500 | 85,800 | 87,000 | 75,700 | 80,000 | 93,000 | 106,000 | 117,000 | 329,200 | 287,000 | 255,000 | 0 | 0 | 0 | - | - | - | - |
Proceeds from exercise of stock options | |||||||||||||||||
2,200 | 1,900 | 800 | 500 | 1,700 | 2,000 | 3,800 | 3,500 | 4,400 | 4,600 | 2,800 | 0 | 0 | 0 | - | - | - | - |
Proceeds from shares issued under employee stock purchase plan | |||||||||||||||||
3,700 | 3,700 | 3,800 | 3,800 | 3,800 | 3,800 | 3,300 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Excess tax benefits from share-based compensation | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 2,400 | 0 | 0 | 0 | - | - | - | - |
Other financing activities | |||||||||||||||||
0 | 0 | - | - | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Net cash used in financing activities | |||||||||||||||||
33,400 | 1,000 | -100 | 5,800 | -69,300 | -76,700 | -90,400 | -94,100 | 180,500 | 234,700 | 263,300 | 263,200 | -21,700 | -44,500 | -36,800 | 0 | 0 | 0 |
Effects of exchange rate changes on cash and cash equivalents and restricted cash | |||||||||||||||||
-300 | -600 | -700 | -700 | -1,300 | -1,000 | -500 | -300 | 400 | 300 | 900 | 700 | 700 | 400 | 100 | 0 | 0 | 0 |
Net increase in cash and cash equivalents and restricted cash | |||||||||||||||||
-6,900 | -25,100 | -22,100 | -23,700 | -23,800 | -38,500 | -30,800 | -35,900 | -23,600 | 40,800 | 47,400 | 55,200 | 41,500 | 19,200 | 15,900 | 0 | 0 | 0 |
Supplemental cash flow information: | |||||||||||||||||
Cash paid for interest | |||||||||||||||||
20,000 | 21,900 | 19,900 | 18,400 | 18,500 | 17,300 | 19,300 | 20,000 | 18,800 | 14,800 | 9,800 | 0 | 0 | 0 | - | - | - | - |
Cash paid for income tax | |||||||||||||||||
14,300 | 8,100 | 8,200 | 5,000 | 2,200 | 14,200 | 13,800 | 16,000 | 17,900 | 6,200 | 6,000 | 0 | 0 | 0 | - | - | - | - |
Supplemental non-cash activities: | |||||||||||||||||
Purchases of property, plant and equipment financed through accounts payable | |||||||||||||||||
2,100 | 800 | 1,800 | -300 | -2,900 | 1,800 | 2,000 | 5,100 | 6,900 | 2,400 | 4,000 | 900 | 2,100 | 3,100 | 3,100 | 0 | 0 | 0 |
Transfers of property, plant and equipment from Varian Medical Systems, Inc. | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |